![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1256, 2000-01, pp. : 9-10
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
UK NICE guidance on GP IIb/IIIa receptor antagonists released
Inpharma, Vol. 1, Iss. 1258, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
GP IIb/IIIa receptor antagonists beneficial in acute coronary syndromes
Inpharma, Vol. 1, Iss. 1221, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Platelet glycoprotein IIb/IIIa receptor antagonists
By Casserly I.P. Moliterno D.J.
Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 3, 2000-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
High-risk subgroup benefits from GP IIb/IIIa antagonists
Inpharma, Vol. 1, Iss. 1324, 2002-01 ,pp. :